Find resources

Total results with these characteristics: 212

Disease: Pneumococcus

Page 11 of 11

This website is a gateway to information from the United States government on vaccines and immunization for infants, children, teenagers, adults, and seniors. It provides resources from US federal agencies for the general public and their …

Author: US Department of Health and Human Services

The Value of Investing in Vaccines

This infographic illustrates the economic benefits of immunization. It is specifically focused on how delivering three childhood vaccines—Haemophilus influenzae type b, pneumococcal, and rotavirus—in the world's 73 poorest countries could result …

Author: International Vaccine Access Center

Publication date: 2012


This online database provides real-time data on vaccine introductions and impact. The Vaccine Information and Epidemiology Window (VIEW-hub) includes information related to rotavirus, pneumococcal, Haemophilus influenzae type b, and inactivated …

Author: International Vaccine Access Center

VIEW-hub – Vaccine Information and Epidemiology Window

This web page provides a link to the most recent VIEW-hub Report, as well as an archive of earlier reports. This quarterly report provides data and figures on the introduction status of Haemophilus influenzae type b, pneumococcal conjugate, …

Author: International Vaccine Access Center

What Do the Next 100 Years Hold for Pneumococcal Vaccination?

This editorial article, published in Expert Review of Vaccines, provides a brief historical overview of vaccination against pneumococcal disease and offers a perspective on the future of pneumococcal vaccines. The authors describe the …

Author: Rijkers GT, van Mens SP, van Velzen-Blad H

Publication date: 2010

What Would Happen if We Stopped Vaccinations?

This web page provides a summary of disease-related consequences of stopping immunizations. Vaccination programs have eliminated or significantly reduced many vaccine-preventable diseases in the United States and elsewhere. However, these diseases …

Author: US Centers for Disease Control and Prevention

Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I

Published in the journal Clinical Infectious Diseases, this study analyzed more than 70 recent data sets to compare the serogroups causing invasive pneumococcal disease with those represented in conjugate vaccine formulations. ABSTRACT ONLY. …

Author: Hausdorff WP, Bryant J, Paradiso P, Siber G

Publication date: 2000

WHO Expert Consultation on Serotype Composition of Pneumococcal Conjugate Vaccines for Use in Resource-Poor Developing Countries, 26–27 October 2006, Geneva.

Published in the journal Vaccine, this article reports on a World Health Organization expert consultation to formulate a data-driven approach to determine the minimum or optimal formulation of pneumococcal conjugate vaccines, particularly keeping in …

Author: Cherian T

Publication date: 2007

WHO Policy Development Processes for a New Vaccine: Case Study of Malaria Vaccines

This article, published in Malaria Journal, analyzed the World Health Organization policy development process to predict its course for a malaria vaccine. Data needs for a malaria vaccine include safety; the demonstration of efficacy in a range of …

Author: Milstien J, Cardenas V, Cheyne J, Brooks A

Publication date: 2010

WHO Prequalified Vaccines

This web page provides a database of vaccines prequalified by the World Health Organization which allows the user to search by manufacturer, vaccine, or country of manufacture. The database is tailored to support immunization program managers, …

Author: World Health Organization

WHO Vaccine Reaction Rates Information Sheets

This web page provides links to information sheets on reaction rates of selected vaccines. The papers are primarily designed for use by national public health officials and immunization program managers. Data from these sheets can be used for the …

Author: World Health Organization

World Health Organization Definition of "Radiologically Confirmed Pneumonia" May Under-estimate the True Public Health Value of Conjugate Pneumococcal Vaccines

The public health benefit of conjugate pneumococcal vaccine (PCV) in preventing pneumonia would only be appreciated if the tool used for measuring “pneumococcal pneumonia” had good sensitivity. Exploratory studies in South Africa …

Author: Madhi S, Klugman K

Publication date: 2007

Page 11 of 11